Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa

Author(s): Alexandre R. de Mello Schier, Natalia P. de Oliveira Ribeiro, Danielle S. Coutinho, Sergio Machado, Oscar Arias-Carrion, Jose A. Crippa, Antonio W. Zuardi, Antonio E. Nardi, Adriana C. Silva.

Journal Name:CNS & Neurological Disorders - Drug Targets

Volume 13 , Issue 6 , 2014

Abstract:

Anxiety and depression are pathologies that affect human beings in many aspects of life, including social life, productivity and health. Cannabidiol (CBD) is a constituent non-psychotomimetic of Cannabis sativa with great psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound. The aim of this study is to review studies of animal models using CBD as an anxiolytic-like and antidepressant-like compound. Studies involving animal models, performing a variety of experiments on the above-mentioned disorders, such as the forced swimming test (FST), elevated plus maze (EPM) and Vogel conflict test (VCT), suggest that CBD exhibited an anti-anxiety and antidepressant effects in animal models discussed. Experiments with CBD demonstrated non-activation of neuroreceptors CB1 and CB2. Most of the studies demonstrated a good interaction between CBD and the 5-HT1A neuro-receptor.

Keywords: Anxiety, anxiolytic-like, cannabis sativa, cannabidiol, CBD, major depression.

Rights & PermissionsPrintExport

Article Details

VOLUME: 13
ISSUE: 6
Year: 2014
Page: [953 - 960]
Pages: 8
DOI: 10.2174/1871527313666140612114838
Price: $58

Article Metrics

PDF: 59
HTML: 0
EPUB: 0
PRC: 0